Direct human evidence of mTOR dysregulation in Lyme disease is lacking; however, Borrelia modulates immunometabolic programs, including PI3K/Akt/mTOR, in human immune cells ex vivo, and Borrelia-induced cytokine production depends on glycolysis/HIF-1α. The gene discussed is MTOR; the disease is Lyme disease.